As the specialist authority for menopause and post reproductive health in the UK, the British Menopause Society plays a pivotal role in shaping best-practice menopause care.
The British Menopause Society strongly encourages healthcare professionals to practice within national and international guidelines.
The British Menopause Society has developed a comprehensive education programme for healthcare professionals and others working in the area of post reproductive health. This is to support healthcare professionals in providing the highest levels of care for their patients.
All British Menopause Society education and guidelines are evidence-based and peer reviewed. They incorporate recommendations for best practice which are included in national and international guidelines. This is achieved through close collaboration with other specialist organisations, Royal Colleges and national and international stakeholders. The British Menopause Society firmly believes that a lack of evidence of harm should not in itself be viewed as evidence of patient safety.
In recent years, the profile and awareness of menopause has increased exponentially and the British Menopause Society welcomes this development. Many more women now have a greater awareness of menopause and perimenopause and many are receiving good evidence-based treatment.
To continue to facilitate best practice, the British Menopause Society has worked closely with other specialist authorities releasing several safety alerts and joint statements. This collaborative effort has led to the publication of position statements and guidelines in conjunction with the Royal College of General Practitioners, Royal College of Nursing Women’s Health Forum, Royal College of Obstetricians & Gynaecologists, Faculty of Sexual & Reproductive Healthcare, Society for Endocrinology, Getting It Right First Time (GIRFT), British Society of Gynaecological Endoscopy and the British Gynaecological Cancer Society.
Close alignment with other established specialist organisations underscores a dedicated commitment to promoting evidence-based menopause care for women. The British Menopause Society firmly stands by its published guidelines.
Referenced BMS Joint guidelines, safety alerts and position statements
BMS Statement on Testosterone [July 2024]
BMS joint guideline Management of unscheduled bleeding on hormone replacement therapy (HRT)
BMS joint guideline: Management of menopausal symptoms following treatment of gynaecological cancer
BMS Statement on Testosterone [March 2023]
Joint BMS FSRH RCGP RCOG SfE and RCN Women’s Health Forum safety alert